Navigation Links
MGT Capital Investments, Inc. Provides Update on Recent Developments
Date:8/22/2011

NEW YORK, Aug. 22, 2011 /PRNewswire/ -- MGT Capital Investments, Inc. ("MGT", "we", or "the Company") (AMEX: MGT), a holding company engaged in the medical imaging industry, is providing the following update on recent developments at the Company and its majority-owned subsidiary Medicsight PLC ("Medicsight" or "MDST").  In addition, MGT is reporting a summary of its recently filed financial results (via SEC Form 10-Q on August 15, 2011) for the period ending June 30, 2011.

Highlights:

  • On July 8, 2011, both the Company and Medicsight announced the initiation of internal investigations through Special Committees of the Boards of Directors relating to the potential misappropriation and/or misdirection of corporate funds.  Based upon the substantially complete results of the investigation, the Company has concluded that no adjustments or restatement of prior issued financial statements is required.  Although the investigation remains on-going, the Board is confident that the Company's financial statements will not require a material restatement as a result of any additional irregularities discovered in the future.  Furthermore, the Company intends to seek all possible methods of recovery or restitution where appropriate and where the cost of doing so will not be greater than the expected outcome.

  • In late July 2011, Medicsight was informed by the Japanese Ministry of Health, Labor and Welfare ("MHLW") that several statistical data errors were encountered in their review of the application for approval of its MedicRead software for use in CT Colonography procedures.  Following informal guidance from MHLW, the Company has decided to withdraw the current submission and is assessing the next course of action.  In the meantime, the Board of Directors of Me
    '/>"/>

SOURCE MGT Capital Investments, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
2. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
3. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
4. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
5. Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments
6. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
7. Atlanta-based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Failure Monitoring
8. Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million
9. Baxa Addresses Health-System Capital Shortage With New Programs for IntelliFlowRx(TM) and IntelliFill i.v.(R)
10. New Fall Allergy Capitals(TM) Reveal the Most Challenging Cities for Allergy Sufferers
11. Accumetrics Announces $16.5M in New Capital Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cnq7tc/medical_device ) ... Device Studies: Clinical Evidence (London, UK - November ... This course has been designed specifically ... evidence required for medical devices and in-vitro diagnostic ... devices and the emphasis on high quality, appropriate ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurocrine Biosciences, Inc. ... Coughlin , Chief Financial Officer of Neurocrine Biosciences, will ... New York City . ... at 11:25am ET (8:25am PT).  The presentation will be ... at http://www.neurocrine.com .   Listeners are ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/r6wspz/drug_delivery_in ) has ... "Drug Delivery in Central Nervous System Diseases ... offering. Advances in understanding of ... new avenues and possibilities for improved drug delivery ... enzymes, and receptors that control the penetration of ...
Breaking Medicine Technology:Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3
... PSTX) today announced that The Mount Sinai Hospital in New York City has implemented its Safety-Sponge System. , ... , , ... ... ...
... N.J. , March 15 Regado Biosciences, Inc., ... with active control agents, announced that Chris Rusconi , ... Zelenkofske , DO, FACC, Senior Vice President , Chief Medical ... on Monday, March 15, 2010 in Atlanta, ...
Cached Medicine Technology:Patient Safety Technologies, Inc., Contracts to Implement the Safety-Sponge(TM) System at The Mount Sinai Hospital in New York 2Patient Safety Technologies, Inc., Contracts to Implement the Safety-Sponge(TM) System at The Mount Sinai Hospital in New York 3Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 2Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 3Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 4
(Date:9/2/2015)... ... September 02, 2015 , ... A UPMC and ... earned international recognition as a premier center for treatment of and research into ... internal bleeding and stroke. , Cure HHT, previously known as The HHT ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... naturopathic and allopathic medicine, opens its second location this week at 31542 S. ... 1000 square feet of lounge space for patients to relax while receiving safe ...
(Date:9/2/2015)... ... September 02, 2015 , ... Ericson is a noted speaker and educator in ... Associate Director of Education for the Association for Clinical Documentation Improvement Specialists (ACDIS) where ... Boot Camps. She serves as a CDI subject matter expert for a variety of ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... Administrators is taking action after seeing a significant increase in unlawful tactics ... Review division has found many cases of OON ASCs encouraging members to have ...
(Date:9/2/2015)... ... 2015 , ... The 2015 China Overseas Investment and Entrepreneurship ... conference will be hosted at five star Beijing Kunlun Hotel and Diaoyutai State ... feature leading EB-5 industry professionals and Chinese private equity partners looking for international ...
Breaking Medicine News(10 mins):Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2
... KNOXVILLE, Tenn.--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) announced preliminary results ... the treatment of metastatic melanoma, the most aggressive form ... efficacy and bystander effect on melanoma tumors in stage ... Provecta in a total of 20 subjects at two ...
... infectious diseases and developing preventive vaccines is the ability ... response over time. An Emory-led team of scientists has ... are able to evade the immune response. The ... of the National Academy of Sciences. , Using a ...
... (TB) experts at Johns Hopkins and in Brazil have ... of drugs used to treat the highly contagious form ... to cure the illness from six months to four. ... antibiotics increased by 17 percent the number of patients ...
... survey [1] analysing how cancer research is funded ,shows ... contributor to the global ,cancer research effort. , Prof ... Forum (ECRM), launched the organisations second survey, which looks ... 2004, at the European Parliament today (Tuesday 18 September). ...
... a Year, TAMPA, Fla., Sept. 18 In response ... a two-week coma with a craving for The,Melting Pot, the ... The Melting Pot will fly Jill Finley and her family ... at its annual,meeting. On May 26, Finley,s husband Ryan ...
... College of Medicine of Yeshiva University has been awarded a ... of Health to further the medical schools study of centenarians ... Nir Barzilai, director of Einsteins Institute for Aging Research, the ... genes that appear to contribute to exceptional longevity in humans, ...
Cached Medicine News:Health News:Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study 2Health News:Chronic infection persists by targeting stromal cell network in lymphoid organs 2Health News:New antibiotic drug combo to speed up treatment of tuberculosis 2Health News:New antibiotic drug combo to speed up treatment of tuberculosis 3Health News:New antibiotic drug combo to speed up treatment of tuberculosis 4Health News:Launch of second European Cancer Research Funding survey 2Health News:Launch of second European Cancer Research Funding survey 3Health News:Launch of second European Cancer Research Funding survey 4Health News:Update on Jill Finley Story, Coma Survivor 2Health News:NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity 2
AUTION ELEVEN is the eleventh model of AUTION series which is ideal for use in small-to-medium-sized hospitals and clinics with its smart design and features....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Stat Detection of Soluble Fibrin Monomer Complexes by the Hemagglutination Technique, 32 tests....
Medicine Products: